Natalizumab is effective as second line therapy in the...

European Journal of Neurology 2009 Vol. 16; Iss. 3

Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis

N. Putzki, K. Kollia, S. Woods, E. Igwe, H. C. Diener, V. Limmroth
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Year:
2009
Language:
english
Pages:
3
DOI:
10.1111/j.1468-1331.2008.02519.x
File:
PDF, 62 KB
english, 2009
Conversion to is in progress
Conversion to is failed